Trials / Conditions / Group B Streptococcus

Group B Streptococcus

12 registered clinical trials studyying Group B Streptococcus — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry NCT06896526	Precia Group	—
Recruiting	Preparing for Maternal GBS Vaccine Trials in Africa NCT06833957	Barcelona Institute for Global Health	—
Unknown	Developing a Controlled Human Infection Model for Group B Streptococcus (CHIM_GBS) NCT04059510	St George's, University of London	—
Completed	Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor NCT02511444	MemorialCare Health System	N/A
Completed	Group B Streptococcus: Attitudes to Immunisation in Pregnancy NCT01982084	University of Oxford	—
Completed	Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women NCT01150123	Novartis Vaccines	Phase 1
Unknown	Group B Streptococcus (GBS) Polymerase Chain Reaction (PCR) Concordance Study NCT00972894	HCA International Limited	—
Completed	The Prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center NCT01251289	Unity Health Toronto	—
Terminated	Oral Penicillin and Penicillin Levels in Venous Umbilical Cord Blood NCT00823433	Corewell Health East	EARLY_Phase 1
Completed	Membrane Sweeping in Group B Streptococcus (GBS) Positive Patients NCT01180023	George Washington University	N/A
Completed	Management of Infants Born to Group B Streptococcus Positive Mothers. NCT00716781	IRCCS Burlo Garofolo	—
Completed	Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines NCT00008853	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1